Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators
In recent years, new drug discovery approaches based on novel pharmacological concepts have emerged. Allosteric modulators, for example, target receptors at sites other than the orthosteric binding sites and can modulate agonist-mediated activation. Interestingly, allosteric regulation may allow a f...
Main Authors: | Víctor Fernández-Dueñas, Mingcheng Qian, Josep Argerich, Carolina Amaral, Martijn D.P. Risseeuw, Serge Van Calenbergh, Francisco Ciruela |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/7/1532 |
Similar Items
-
NanoBRET: The Bright Future of Proximity-Based Assays
by: Natasha C. Dale, et al.
Published: (2019-03-01) -
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
by: James Maksymetz, et al.
Published: (2017-04-01) -
Investigation of Receptor Heteromers Using NanoBRET Ligand Binding
by: Elizabeth K. M. Johnstone, et al.
Published: (2021-01-01) -
An Integrated Approach toward NanoBRET Tracers for Analysis of GPCR Ligand Engagement
by: Michael P. Killoran, et al.
Published: (2021-05-01) -
Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor
by: Hirohiko Hikichi, et al.
Published: (2015-03-01)